Venous Thrombosis (VT)
Open Solicitation Posted
- Solicitation number
- 80JSC026Q0014
- Agency
-
Johnson Space Center
National Aeronautics and Space Administration
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Houston, Texas, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
NASA Johnson Space Center is soliciting quotations under RFQ 80JSC026Q0014 for venous thrombosis (VT) countermeasures research and development services supporting spaceflight and exploration missions, with quotations due November 20, 2026. The procurement is full and open with no set-aside, and it is a new requirement with no incumbent or follow-on contract. The notice is a combined synopsis/solicitation under FAR Part 12 for commercial products and services, with NAICS 541715 and a 1,000-employee size standard. The PSC is AN22.
Place of performance is NASA Johnson Space Center, Houston, Texas, with FOB Destination delivery and contractor-borne transportation costs. Quotes may address one or more areas: approaches to surveil, reduce risk of, and prevent or treat VT; point-of-care devices functional in weightlessness or reduced gravity; mechanical countermeasures; and future spaceflight or spaceflight analog research. Retrospective analysis of existing datasets, ground-based analog research, and novel VT assessment technologies are responsive. Basic science, animal experiments, tissue chip/organoid pathophysiology, Earth-independent decision-support tools, emerging VT pharmaceuticals, and AI/ML modeling are excluded. Modeling is acceptable only where it directly implements surveillance or countermeasures. Offerors must independently arrange and fund any parabolic flights, and the Government directs proposers to prioritize ISS data collection.
Government-provided retrospective material includes moderate quantities of pre- and inflight serum, plasma, and urine samples from more than 20 astronauts, with corresponding ultrasound imaging; the Human Research Program coordinates distribution after award. Proposers should assume a 50% consent rate, and crew rotations average 6-8 months with 1-3 research participants per mission. Schedules and budgets must account for NASA's inability to guarantee manifesting on commercial providers. Responses must comply with the HERO NOFO framework under Dual-Anonymous Peer Review, with a 10-page anonymized project description and attributable information, including team qualifications, certifications, and CVs, in a separate section.
Evaluation proceeds in two steps: noncompliant quotes are eliminated, then compliant quotes are traded off across Technical Acceptability (Scientific Merit Review and Programmatic Relevancy Review, rated Outstanding, Acceptable, or Unacceptable), Past Performance (rated Acceptable, Neutral, or Unacceptable, drawing on CPARS and SAM.gov), and Price. Technical and past performance combined are significantly more important than price, though price weight rises as technical and past performance ratings converge.
No budget ceiling, maximum award size, or anticipated number of awards is stated, and the Government reserves the right to make multiple awards. Pricing is firm fixed price via Attachment D, quotes must remain valid for 90 days, and a detailed budget with separate institutional F&A and fringe rates is highly recommended. Universities are eligible, and American vendors may propose international collaborators subject to FAR 52.204-7 and 52.225-5. Amendment 0002 extended the period of performance end date to September 30, 2031. Amendment 0003 extended the question deadline to October 30, 2026 at 1:00 PM CST and added four one-year options under FAR 52.217-9, which limits total contract duration, including options, to five years. Amendment 0004, issued November 9, 2026, replaced the Questions and Answers attachment without extending the offer deadline. Contracting Officer Katelyn Jaime and Contract Specialist Joshua R. Hlavenka are the points of contact.
Notice text
5 versions
Update #5 · Latest ·
Amendment 004:
The purpose of this amendment is to update the "Attachment E - Questions and Answers 11.09.26" to include more questions and responses. If you don't see you questions word for word, questions may have been generalized, combined, or altered to protect proper protocols.
Amendment 003:
The purpose of this amendment is to update the CLIN structure, add clauses, and attach Attachment E - Questions and Answers.
We have also extended the question due date to close on 10/30/2026 at 1:00PM CST
We have not answered all questions recieved at this time, answers are still in works, please continue to monitor SAM.gov for updates.
Amendment 002:
The purpose of this amendment is to fix admin errors on the CLIN. Please see SF30.
Amendment 001:
The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis".
__________________________________________________
Base
Venous Thrombosis RFQ:
This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued.
This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) .
The provisions and clauses in the RFQ are those in effect through FAC 2026-01
The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition.
All responsible sources may submit an offer which must be considered by the agency.
Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination.
The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV
NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf
Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incorporated by reference.
The items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.
FAR 52.212-2, Evaluation -- Commercial Products and Commercial Services
The Government will award a contract resulting from this solicitation to the offer responsible, whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors are in descending order of importance and must be used to evaluate offers: Technical Acceptability, Past Performance, and Price. Technical and Past Performance, when combined, are significantly more important than price.
FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services is applicable
NASA Clause 1852.215-84, Ombudsman, is applicable. The Center Ombudsman for this acquisition can be found at: https://www.hq.nasa.gov/office/procurement/regs/Procurement-Ombuds-Comp-Advocate-Listing.pdf
This posting, in addition to any attached documents, will be available on www.Sam.gov. Potential offerors will be responsible for downloading their own copy of this combination synopsis/solicitation and amendments (if any).
Prospective offerors are encouraged to notify this office of their intent to submit an offer. All contractual and technical questions must be submitted electronically via email to John Russo at john.d.russo@nasa.gov and Katelyn Jaime at katelyn.r.jaime@nasa.gov not later than 1:00 PM CST on 10/30/2026. Telephone questions will not be accepted.
Responses to this combined synopsis/solicitation (with concurrence by the offeror’s institutional Authorized Organizational Official (AOR) if applicable) must be received via email no later than 1:00PM CST on 11/20/2026.
The Government is not responsible for any failure attributable to the transmission or receipt of documents submitted using electronic means, including the missing of any established deadlines.
Failure to submit a complete electronic proposal by the due date and time specified for this RFQ must result in the proposal being considered late and must be handled in accordance with FAR 52.212-1 Instructions to Offerors - Commercial Products and Commercial Services.
Update #4 ·
Amendment 003:
The purpose of this amendment is to update the CLIN structure, add clauses, and attach Attachment E - Questions and Answers.
We have also extended the question due date to close on 10/30/2026 at 1:00PM CST
We have not answered all questions recieved at this time, answers are still in works, please continue to monitor SAM.gov for updates.
Amendment 002:
The purpose of this amendment is to fix admin errors on the CLIN. Please see SF30.
Amendment 001:
The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis".
__________________________________________________
Base
Venous Thrombosis RFQ:
This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued.
This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) .
The provisions and clauses in the RFQ are those in effect through FAC 2026-01
The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition.
All responsible sources may submit an offer which must be considered by the agency.
Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination.
The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV
NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf
Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incorporated by reference.
The items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.
FAR 52.212-2, Evaluation -- Commercial Products and Commercial Services
The Government will award a contract resulting from this solicitation to the offer responsible, whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors are in descending order of importance and must be used to evaluate offers: Technical Acceptability, Past Performance, and Price. Technical and Past Performance, when combined, are significantly more important than price.
FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services is applicable
NASA Clause 1852.215-84, Ombudsman, is applicable. The Center Ombudsman for this acquisition can be found at: https://www.hq.nasa.gov/office/procurement/regs/Procurement-Ombuds-Comp-Advocate-Listing.pdf
This posting, in addition to any attached documents, will be available on www.Sam.gov. Potential offerors will be responsible for downloading their own copy of this combination synopsis/solicitation and amendments (if any).
Prospective offerors are encouraged to notify this office of their intent to submit an offer. All contractual and technical questions must be submitted electronically via email to John Russo at john.d.russo@nasa.gov and Katelyn Jaime at katelyn.r.jaime@nasa.gov not later than 1:00 PM CST on 10/30/2026. Telephone questions will not be accepted.
Responses to this combined synopsis/solicitation (with concurrence by the offeror’s institutional Authorized Organizational Official (AOR) if applicable) must be received via email no later than 1:00PM CST on 11/20/2026.
The Government is not responsible for any failure attributable to the transmission or receipt of documents submitted using electronic means, including the missing of any established deadlines.
Failure to submit a complete electronic proposal by the due date and time specified for this RFQ must result in the proposal being considered late and must be handled in accordance with FAR 52.212-1 Instructions to Offerors - Commercial Products and Commercial Services.
Update #3 ·
Amendment 002:
The purpose of this amendment is to fix admin errors on the CLIN. Please see SF30.
Amendment 001:
The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis".
__________________________________________________
Base
Venous Thrombosis RFQ:
This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued.
This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) .
The provisions and clauses in the RFQ are those in effect through FAC 2026-01
The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition.
All responsible sources may submit an offer which must be considered by the agency.
Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination.
The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV
NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf
Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incorporated by reference.
The items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.
FAR 52.212-2, Evaluation -- Commercial Products and Commercial Services
The Government will award a contract resulting from this solicitation to the offer responsible, whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors are in descending order of importance and must be used to evaluate offers: Technical Acceptability, Past Performance, and Price. Technical and Past Performance, when combined, are significantly more important than price.
FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services is applicable
NASA Clause 1852.215-84, Ombudsman, is applicable. The Center Ombudsman for this acquisition can be found at: https://www.hq.nasa.gov/office/procurement/regs/Procurement-Ombuds-Comp-Advocate-Listing.pdf
This posting, in addition to any attached documents, will be available on www.Sam.gov. Potential offerors will be responsible for downloading their own copy of this combination synopsis/solicitation and amendments (if any).
Prospective offerors are encouraged to notify this office of their intent to submit an offer. All contractual and technical questions must be submitted electronically via email to John Russo at john.d.russo@nasa.gov and Katelyn Jaime at katelyn.r.jaime@nasa.gov not later than 1:00 PM CST on 10/25/2026. Telephone questions will not be accepted.
Responses to this combined synopsis/solicitation (with concurrence by the offeror’s institutional Authorized Organizational Official (AOR) if applicable) must be received via email no later than 1:00PM CST on 11/20/2026.
The Government is not responsible for any failure attributable to the transmission or receipt of documents submitted using electronic means, including the missing of any established deadlines.
Failure to submit a complete electronic proposal by the due date and time specified for this RFQ must result in the proposal being considered late and must be handled in accordance with FAR 52.212-1 Instructions to Offerors - Commercial Products and Commercial Services.
Update #2 ·
Amendment 001:
The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis".
__________________________________________________
Base
Venous Thrombosis RFQ:
This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued.
This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) .
The provisions and clauses in the RFQ are those in effect through FAC 2026-01
The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition.
All responsible sources may submit an offer which must be considered by the agency.
Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination.
The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV
NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf
Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incorporated by reference.
The items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.
FAR 52.212-2, Evaluation -- Commercial Products and Commercial Services
The Government will award a contract resulting from this solicitation to the offer responsible, whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors are in descending order of importance and must be used to evaluate offers: Technical Acceptability, Past Performance, and Price. Technical and Past Performance, when combined, are significantly more important than price.
FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services is applicable
NASA Clause 1852.215-84, Ombudsman, is applicable. The Center Ombudsman for this acquisition can be found at: https://www.hq.nasa.gov/office/procurement/regs/Procurement-Ombuds-Comp-Advocate-Listing.pdf
This posting, in addition to any attached documents, will be available on www.Sam.gov. Potential offerors will be responsible for downloading their own copy of this combination synopsis/solicitation and amendments (if any).
Prospective offerors are encouraged to notify this office of their intent to submit an offer. All contractual and technical questions must be submitted electronically via email to John Russo at john.d.russo@nasa.gov and Katelyn Jaime at katelyn.r.jaime@nasa.gov not later than 1:00 PM CST on 10/25/2026. Telephone questions will not be accepted.
Responses to this combined synopsis/solicitation must be received via email no later than 1:00PM CST on 11/20/2026.
The Government is not responsible for any failure attributable to the transmission or receipt of documents submitted using electronic means, including the missing of any established deadlines.
Failure to submit a complete electronic proposal by the due date and time specified for this RFQ must result in the proposal being considered late and must be handled in accordance with FAR 52.212-1 Instructions to Offerors - Commercial Products and Commercial Services.
Update #1 ·
Venus Thrombosis RFQ:
This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued.
This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venus Thrombosis (VT) .
The provisions and clauses in the RFQ are those in effect through FAC 2026-01
The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition.
All responsible sources may submit an offer which must be considered by the agency.
Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination.
The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV
NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf
Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incorporated by reference.
The items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.
FAR 52.212-2, Evaluation -- Commercial Products and Commercial Services
The Government will award a contract resulting from this solicitation to the offer responsible, whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors are in descending order of importance and must be used to evaluate offers: Technical Acceptability, Past Performance, and Price. Technical and Past Performance, when combined, are significantly more important than price.
FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services is applicable
NASA Clause 1852.215-84, Ombudsman, is applicable. The Center Ombudsman for this acquisition can be found at: https://www.hq.nasa.gov/office/procurement/regs/Procurement-Ombuds-Comp-Advocate-Listing.pdf
This posting, in addition to any attached documents, will be available on www.Sam.gov. Potential offerors will be responsible for downloading their own copy of this combination synopsis/solicitation and amendments (if any).
Prospective offerors are encouraged to notify this office of their intent to submit an offer. All contractual and technical questions must be submitted electronically via email to John Russo at john.d.russo@nasa.gov and Katelyn Jaime at katelyn.r.jaime@nasa.gov not later than 1:00 PM CST on 10/25/2026. Telephone questions will not be accepted.
Responses to this combined synopsis/solicitation must be received via email no later than 1:00PM CST on 11/20/2026.
The Government is not responsible for any failure attributable to the transmission or receipt of documents submitted using electronic means, including the missing of any established deadlines.
Failure to submit a complete electronic proposal by the due date and time specified for this RFQ must result in the proposal being considered late and must be handled in accordance with FAR 52.212-1 Instructions to Offerors - Commercial Products and Commercial Services.
Files
Show all 19
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity